Crystal Denlinger, MD of the Fox Chase Cancer Center discusses Crystal Denlinger Named Chief Scientific Officer for National Comprehensive Cancer…
Browsing: Other
Grzegorz S. Nowakowski, MD from the Mayo Clinic speaks about the Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly…
Conor E. Steuer, MD from the Winship Cancer Institute of Emory University in Atlanta discusses Patients with Lung Cancer Reduce…
Erminia Massarelli, MD Ph.D. from the City of Hope speaks about Lung Cancer: Her Experience, Research, And The Current Treatment…
Uri Ben-David, Ph.D. Assistant Professor, Department of Human Molecular Genetics and Biochemistry at the Tel Aviv University speaks about the…
Gypsyamber D’Souza, Ph.D. from Johns Hopkins, Bloomberg School of Public Health speaks about Timing, number, and type of sexual partners…
Guillermo Garcia-Manero, MD from The University of Texas MD Anderson Cancer Center speaks about ASH 2020 Abstract – 1230 Clinical…
Andreana N. Holowatyj, Ph.D., MS Assistant Professor of Medicine and Cancer Biology from Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center…
Nathan Connell, MD, MPH, FACP of Brigham and Women’s Hospital, Harvard Medical School speaks about ASH ISTH NHF WFH 2021…
Aung Naing, MD, FACP of MD Anderson discusses the Phase 2 study of pembrolizumab in patients with advanced rare cancers.InstractContext:There…
Omar M. Abdel-Rahman Abdelsalam, MBBCh, MSc, MD, Assistant Professor of Medical Oncology from the University of Alberta discusses the New…
Aung Naing, MD, FACP MD Anderson speaks about Strategies for improving the management of immune-related adverse events.You can download the…
R. Stephanie Huang, Ph.D. of the University of Minnesota and R.S. Huang Lab discusses Computationally predicting clinical drug combination efficacy…
Ron Peck, MD, Chief Medical Officer of Arvinas speaks about Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential…
Javid Moslehi, MD and Justin M. Balko, Pharm.D., Ph.D. from Vanderbilt-Ingram Cancer Center discuss A genetic mouse model recapitulates immune…
Gelareh Zadeh, M.D., Ph.D., FRCS(C), FAANS, professor and dan chair of Neurosurgery at the University of Toronto, head of the…
Robert Zeiser, MD of the University Medical Center, Freiburg Im Breisgau discusses the ASH abstract – 77 Ruxolitinib (RUX) Vs…
Steven W. Pipe, MD of the University of Michigan, Ann Arbor speaks about ASH 2020 abstract – Gene Therapy for…
Clint Valentine, MS from TwinStrand Biosciences discusses TwinStrand Biosciences Announces Peer-Reviewed Publication of Study Results Highlighting Ability of Duplex Sequencing…
Jyoti Nangalia, MBBChir of the Wellcome Sanger Institute, Hinxton, United Kingdom, University of Cambridge, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge,…
Mukta Arora, MD, PI and Professor of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota speaks about the…
Brian Van Tine, MD, Ph.D. of Washington University of School of Medicine, in St. Louis speaks about Spearhead 1 Study…
John Mascarenhas, MD of the Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute speaks about the ASH 2020…
John Mascarenhas, MD of the Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute speaks about the ASH 2020…
Douglas Blayney, MD, Professor of Medicine (Oncology) of Stanford University Medical Center discusses the SABCS 2020 abstract – The Timing…
Kimberly C Jenkins, MSNM from the Cleveland Clinic discusses the ASH 2020 abstract – 3441 Increased Productivity and Efficiency Among…
Naveen Pemmaraju, MD of MD Anderson speaks about Blastic Plasmacytoid Dendritic Cell Neoplasm.ContextNatural killer (NK) cell leukemia/lymphoma was historically identified…
Lee Zuckerman, MD Orthopedic Surgeon at the City of Hope, a comprehensive cancer center near Los Angeles discusses Use of…
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Anthony Yanni, M.D., Senior Vice President, patient-centricity at…
Klaus Hoeflich, Ph.D. Senior Vice President, Biology at Blueprint Medicines Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust…
Natasha Leighl, MD Princess Margaret Cancer Centre speaks on the press release Liquid biopsies timely and effective testing method for…
Vishruta A. Dumane, Ph.D., Assistant Professor Radiation Oncology of the Icahn School of Medicine at Mount Sinai speaks about the…
Erin Murphy, MD of the Cleveland Clinic discusses the ASTRO 2020 Abstract 2546 Safety of Metastasis-Directed SBRT and Concurrent Pazopanib…
Gregory M. Videtic MD, CM, FRCPC, FACR, FASTRO Section Head for Thoracic Malignancies and Residency Program Director in the Department…
Kunal Sindhu, MD from the Icahn School of Medicine at Mount Sinai speaks about the ASTRO 2020 Abstract 3009 Identifying…
Robert Coleman, MD, FACOG, FACS, Chief Scientific Officer U.S. Oncology Research discusses Elevation Oncology and US Oncology Research Announce Collaboration…
John R. “Jack†Steel, M.D. F.A.C.R.O. of Tampa Bay Radiation Oncology discusses Managing Anxiety During Cancer Treatment. Some of the…
Abby Westerman, founder of b-present Foundation – Astellas discusses Astellas Oncology Opens Annual C3 Prize® Call for Entries to Award…
Andy Krivoshik, MD, Ph.D. – Astellas Oncology discusses Astellas Oncology Opens Annual C3 Prize® Call for Entries to Award the…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Tim Blauwkamp, Ph.D., Chief Scientific Officer and co-founder…
Matthew P. Goetz, MD of Mayo Clinic @MayoClinic discusses acquired genomic alterations in circulating tumor DNA from patients receiving abemaciclib…
Matthew P. Goetz, MD of Mayo Clinic @MayoClinic discusses acquired genomic alterations in circulating tumor DNA from patients receiving abemaciclib…
Timothy A Yap, MD, PhD of MD Anderson Cancer Center @MDAndersonNews discusses AVID200, first-in-class TGF-beta 1 and 3 selective and…
Timothy A Yap, MD, PhD of MD Anderson Cancer Center @MDAndersonNews discusses AVID200, first-in-class TGF-beta 1 and 3 selective and…
Timothy A Yap, MD, PhD of MD Anderson Cancer Center @MDAndersonNews discusses AVID200, first-in-class TGF-beta 1 and 3 selective and…